Wenzhao Lu
Chairman of the BoardMr. Wenzhao Lu, also known as Daniel, serves as Chairman of the Board of Directors at Change Agents Corporation (formerly known as Avalon GloboCare Corp.) and Avalon Healthcare System, Inc since October 10, 2016. He serves as Director at Change Agents Corporation (formerly known as Avalon GloboCare Corp.) since October 10, 2016. He served as Chief Operating Officer for BioTime Asia Limited, a subsidiary of BioTime, Inc. since 2009. Mr. Lu worked as senior Art Director at Ogilvy & Mather Advertising Company. He is a seasoned healthcare entrepreneur with operational knowledge and experience in China. He had been Chairman of the Board for the DaoPei Medical Group from 2010 to December, 2021. Under his leadership, DPMG has expanded its clinical network involving a state-of-the-art stem cell bank at Wuhan Biolake, three top-ranked private hospitals (located in Beijing, Shanghai, and Hebei), specialty hematology laboratories, as well as a hematology research institute, with more than 100 Partnering and collaborating hospitals in China. He served as Chairman of Global Technologies Corp. and served as its Director since October 10, 2016. Mr. Lu received a Bachelor of Arts from Temple University Tyler School of Arts in 1988.
Positions
- Company NameChange Agents CorporationStock CodeCHGAPositionChairman of the Board
